<DOC>
	<DOC>NCT01152242</DOC>
	<brief_summary>The purpose of this study is to evaluate whether the within-subject variation in duration of action and time-action profile of glargine measured by isoglycemic clamp will be below prespecified levels.</brief_summary>
	<brief_title>Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Part 1: Patient is a male between 18 to 45 years of age (inclusive) at the prestudy (screening) visit Patient has a clinical diagnosis of type 1 diabetes Patient must have been treated with insulin since diagnosis and be on a stable dose of insulin Patient has a Body Mass Index (BMI) of &lt;=27 kg/m2 and &gt;18 kg/m2 Patient has been a nonsmoker and/or has not used nicotine or nicotinecontaining products for at least approximately 6 months Part 2: Subject is a male between 18 to 45 years of age at the prestudy (screening) visit Subject has a Body Mass Index (BMI) of &lt;=25 kg/m^2 Subject has been a nonsmoker and/or has not used nicotine or nicotinecontaining products for at least approximately 6 months Part 1: Patient has a history of stroke, chronic seizures, or major neurological disorder Patient has currently active and untreated clinically significant endocrine, cardiovascular, hematological, hepatic, renal, respiratory, or genitourinary abnormalities or diseases Patient has a history of hypertension requiring treatment Patient has a history of neoplastic disease within the past 5 years Patient is currently being treated with, or has a history of treatment with any oral antihyperglycemic agent Patient has a history of significant multiple and/or severe allergies Part 2: Subject has a history of stroke, chronic seizures, or major neurological disorder Subject has a history of hypertension requiring treatment Subject has a history of neoplastic disease within the past 5 years Subject has history of diabetes (Type 1, Type 2 or steroidinduced) or family history of diabetes mellitus Subject has a history of hypersensitivity to glargine or any of its inactive ingredients</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Insulin</keyword>
</DOC>